Inovio Pharmaceuticals (INO) Buy Rating Reiterated at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright earlier retreated a Buy rating on Inovio Pharmaceuticals (NASDAQ: INO) with a price target of $17. Comments follow ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
